Correlations between Tumor Antigenicity, Malignant Potential, and Local Host Immune Response

  • Harry L. Ioachim
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 10)


In the process of induction and growth of tumors, complex interrelationships are established between tumor and host. Among the multiple participating factors, some are particularly important in determining the outcome of tumor growth. To understand this complex interrelationship, it is therefore necessary to identify the determinant factors of tumor-host interaction and to study their functions.


Squamous Cell Carcinoma Plasma Cell Malignant Potential Cellular Reaction Cellular Infiltrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander, P., 1974, Escape from immune destruction by the host through shedding of surface antigens: Is this a characteristic shared by malignant and embryonic cells? Cancer Res. 34: 2077–2082.PubMedGoogle Scholar
  2. Alexander, P., 1977, Back to the drawing board—The need for more realistic model systems for immunotherapy, Cancer 40: 467–470.PubMedCrossRefGoogle Scholar
  3. Baldwin, R. W., Price, M. R., and Robins, R. A., 1972, Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumor-specific antigen-antibody complexes, Nature (London) New Biol. 238: 185–187.CrossRefGoogle Scholar
  4. Baldwin, R. W., Embleton, M. J., and Robins, R. A., 1973, Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumor status, Int. J. Cancer 11: 1–10.PubMedCrossRefGoogle Scholar
  5. Barber, H. R. K., Sommers, S. C., Snyder, R., and Kwon, T. H., 1975, Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer, Am. J. Obstet. Gynecol. 121: 795–804.PubMedGoogle Scholar
  6. Bartlett, G. L., 1972, Effect of host immunity on the antigenic strength of primary tumors, J. Natl. Cancer Inst. 49: 493–504.PubMedGoogle Scholar
  7. Berg, J. W., 1959, Inflammation and prognosis in breast cancer—A search for host resistance, Cancer 12: 714–720.PubMedCrossRefGoogle Scholar
  8. Black, M. M., and Leis, H. P., 1971, Cellular responses to autologous breast cancer tissue, Cancer 28: 263–273.PubMedCrossRefGoogle Scholar
  9. Bubenick, J., Perlman, P., Helmstein, K., and Moberger, G., 1970, Cellular and humoral immune responses to human urinary bladder carcinomas, Int. J. Cancer 5: 310–319.CrossRefGoogle Scholar
  10. Cikes, M., 1975, Antigenic changes in cultured murine lymphomas after retransplantation into syngeneic hosts, J. Natl. Cancer Inst. 54: 903–906.PubMedGoogle Scholar
  11. Dao, T. L., and Kovaric, J., 1962, Incidence of pulmonary and skin metastases in women with breast cancer who received postoperative irradiation, Surgery 52: 203–212.Google Scholar
  12. Dao, T. L., and Yogo, H., 1967, Enhancement of pulmonary metastases by x-irradiation in rats bearing mammary cancer, Cancer 20: 2020–2025.PubMedCrossRefGoogle Scholar
  13. Dorsett, B. H., Ioachim, H. L., Stolbach, L., Walker, J., and Barber, H. R. K., 1975, Isolation of tumor-specific antibodies from effusions of ovarian carcinomas, Int. J. Cancer 16: 779–786.PubMedCrossRefGoogle Scholar
  14. Dorval, G., Witz, I. P., Klein, E., and Wigzell, H., 1976, Tumor-bound immunoglobulins: An in vivo phenomenon of masked specificity, J. Natl. Cancer Inst. 56: 523–527.PubMedGoogle Scholar
  15. Essex, M., Klein, G., Snyder, S. P., and Boyd Harrold, J., 1971, Correlation between humoral antibody and regression of tumors induced by feline sarcoma virus, Nature (London) 233: 195–196.CrossRefGoogle Scholar
  16. Ewing, J., 1940, Neoplastic Diseases, W. B. Saunders, Philadelphia.Google Scholar
  17. Fisher, B., 1970, Postoperative radiotherapy in the treatment of breast cancer—Results of the NSABP clinical trial, Ann. Surg. 172: 711–732.PubMedCrossRefGoogle Scholar
  18. Fisher, E. R., and Fisher, B., 1972, Local lymphoid response as an index of tumor immunity, Arch. Pathol. 94: 137–146.PubMedGoogle Scholar
  19. Fenyö, E. M., Klein, E., Klein, G., and Swiech, K., 1968, Selection of an immunoresistant Moloney lymphoma sublime with decreased concentration of tumor-specific surface antigens, J. Natl. Cancer Inst. 40: 69–89.PubMedGoogle Scholar
  20. Gold, P., 1967, Circulating antibodies against carcino-embryonic antigens of the human digestive system, Cancer 20: 1663–1667.CrossRefGoogle Scholar
  21. Gupta, R. K., and Morton, D. L., 1975, Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas, Cancer Res. 35: 58–62.PubMedGoogle Scholar
  22. Hellström, I., Hellström, K. E., Sjogren, H. 0., 1970, Serum-mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas, Cell Immunol. 1: 18–30.PubMedCrossRefGoogle Scholar
  23. Henle, W., Henle, G., Gunven, P., Klein, G., Clifford, P., and Singh, S., 1973, Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt’s lymphoma, J. Natl. Cancer Inst. 50: 1163–1173.PubMedGoogle Scholar
  24. Herberman, R. B., and Fahey, J. L., 1968, Cytotoxic antibody in Burkitt’s tumor and normal human serum reactive with cultures of lymphoid cells, Proc Soc. Exp. Biol. Med. 127: 938.PubMedGoogle Scholar
  25. Herberman, R. B., and Oren, M. E.,,1971, Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response, J. Natl. Cancer Inst. 46: 391–396.Google Scholar
  26. Ioachim, H. L., 1976, The stromal reaction of tumors: An expression of immune surveillance—Guest editorial, J. Natl. Cancer Inst. 57: 465–475.PubMedGoogle Scholar
  27. Ioachim, H. L., and Sabbath, M., 1979, Redistribution and modulation of Gross murine leukemia virus antigens induced by specific antibodies, J. Natl. Cancer Inst. 62: 169–180.PubMedGoogle Scholar
  28. Ioachim, H. L., Cali, A., and Sinha, D., 1965, Age-dependent transplantability in rats of virus-induced thymic lymphoma cultured in vitro, Cancer Res. 25: 132–139.PubMedGoogle Scholar
  29. Ioachim, H. L., Berwick, L., and Furth, J., 1966, Replication of Gross leukemia virus in longterm cultures of rat thymomas. Bioassays and electron microscopy, Cancer Res. 20: 80–3811.Google Scholar
  30. Ioachim, H. L., Dorsett, B., Sabbath, M., and Keller, S., 1972, Loss and recovery of pheno- typic expression of Gross leukemic virus, Nature (London) New Biol. 237: 215–218.CrossRefGoogle Scholar
  31. Ioachim, H. L., Dorsett, B. H., and Paluch, E., 1974a, Cellular and humoral immune reactions to squamous cell carcinomas of the lung, in: Proceedings of the XIth International Cancer Congress, Vol. 2, p. 104, Florence.Google Scholar
  32. Ioachim, H. L., Keller, S., Sabbath, M., and Dorsett, B. H., 1974b, Antigenic expression as a determining factor of tumor growth in Gross virus lymphoma, Prog. Exp. Tumor Res. 19: 284–296.PubMedGoogle Scholar
  33. Ioachim, H. L., Keller, S., Dorsett, B., and Pearse, A., 1974e, Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma, J. Exp. Med. 139: 1382–1394.PubMedCrossRefGoogle Scholar
  34. Ioachim, H. L., Keller, S., and Dorsett, B., 1975, Transplantability, immunological unresponsiveness, and loss of cellular antigenicity in Gross virus lymphoma, in: Comparative Leukemia Research, 1973. Leukemogenesis (Y. Ito, and R. M. Dutcher, eds.), pp. 301–310, University of Tokyo Press, Tokyo.Google Scholar
  35. Ioachim, H. L., Dorsett, B., and Paluch, E., 1976, The immune response at the tumor site in lung carcinoma, Cancer 38: 2296–2309.PubMedCrossRefGoogle Scholar
  36. Ioachim, H. L., Pearse, A., and Keller, S., 1977a, Antigenic deletion and malignant enhancement induced in lymphoma cells by passage through x-irradiated hosts, Nature (London) 265: 55–57.CrossRefGoogle Scholar
  37. Ioachim, H. L., Pearse, A., and Keller, S., 1977b, Patterns of metastases in hemopoietic neoplasms: Immunologic correlations, in: Cancer Invasion and Metastasis ( S. B. Day, ed.), pp. 333–345, Raven Press, New York.Google Scholar
  38. Trie, K., Irie, R. F., and Morton, D. L., 1975, Detection of antibody and complement cornplexed in vivo on membranes of human cancer cells by mixed hemadsorption techniques, Cancer Res. 35: 1244–1248.Google Scholar
  39. Jamasbi, R. J., and Nettesheim, P., 1977, Increased immunogenicity of a pulmonary squamous cell carcinoma, propagated in vitro, Int. J. Cancer 20: 817–823.PubMedCrossRefGoogle Scholar
  40. Kim, U., Baumler, A., Corruthers, C., and Bielat, K., 1975, Immunological escape mechanism in spontaneously metastasizing mammary tumors, Proc. Natl. Acad. Sci. USA 72: 1012–1016.PubMedCrossRefGoogle Scholar
  41. Klein, G., 1975, Immunological surveillance against neoplasia, Harvey Lect. 69: 71–102.Google Scholar
  42. Klein, G., and Klein, E., 1977, Rejectability of virus-induced tumors and non-rejectability of spontaneous tumors: A lesson in contrasts, Transplant Proc. 9: 1095–1104.PubMedGoogle Scholar
  43. Klein, G., and Sjögren, H. 0., 1960, Humoral and cellular factors in homograft and isograft immunity against sarcoma cells, Cancer Res. 20: 452–461.PubMedGoogle Scholar
  44. Kobayashi, H., Gotohda, E., Hosokawa, M., and Kodama, T., 1975, Inhibition of metastasis in rats immunized with xenogenized autologous tumor cells after excision of the primary tumor, J. Natl. Cancer Inst. 54: 997–999.PubMedGoogle Scholar
  45. Koneval, T., Applebaum, E., Popovic, D., Gill, L., Sissou, G., Wood, G. W., and Anderson, B., 1977, Demonstration of immunoglobulin in tumor and marginal tissues of squamous cell carcinomas of the head and neck, J. Natl. Cancer Inst. 59: 1089–1093.PubMedGoogle Scholar
  46. Kuzumaki, N., Fdnyo, E. M., Giovanella, B. C., and Klein, G., 1978, Increased immunogenicity of low-antigenic rat tumors after superinfection with endogenous murine C-type virus in nude mice, Int. J. Cancer 21: 62–66.PubMedCrossRefGoogle Scholar
  47. Lauder, I., and Aherne, W., 1972, The significance of lymphocytic infiltration in neuro-blastoma, Br. J. Cancer 26: 321–330.PubMedCrossRefGoogle Scholar
  48. Lewis, M. G., McCloy, E., and Blake, J., 1973, The significance of humoral antibodies in the localization of human malignant melanoma, Br. J. Surg. 60: 443–446.PubMedCrossRefGoogle Scholar
  49. Lewis, M. G., Proctor, J. W., Thompson, D. M. P., Rowden, G., and Phillips, T. M., 1976, Cellular localization of immunoglobulin within human malignant melanoma, Br. J. Cancer 33: 260–266.PubMedCrossRefGoogle Scholar
  50. Lewis, M. G., Phillips, T. M., and Rowden, G., 1978, Beneficial and detrimental effects of humoral immunity in malignancy, in: Pathobiology Annual, Vol. 8 ( H. L. Ioachim, ed.), pp. 217–239, Appleton-Century-Crofts, Englewood Cliffs, New Jersey.Google Scholar
  51. Mora, P. T., Chang, C., Couvillion, L., Kuster, J. M., and McFarland, V. W., 1977, Immunological selection of tumor cells which have lost SV40 antigen expression, Nature (London) 269: 36–40.CrossRefGoogle Scholar
  52. Morton, D. L., Malmgren, R. A., Holmes, F. C., and Ketcham, A. S., 1968, Demonstration of antibodies against human malignant melonomas by immunotluorescence, Surgery 64: 233–240.PubMedGoogle Scholar
  53. Murphy, J. B., Nakahara, W., and Sturm, E., 1921, Studies on lymphoid activity. V. Relation between the time and extent of lymphoid stimulation induced by physical agents and the degree of resistance to cancer in mice, J. Exp. Med. 33: 423–428.PubMedCrossRefGoogle Scholar
  54. Paluch, E., and Ioachim, H. L., 1978, Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients, J. Natl. Cancer Inst. 61: 319–325.PubMedGoogle Scholar
  55. Paluch, E., and Ioachim, H. L., 1979, Reactive antibodies in the bronchial washings of lung cancer patients, Int. J. Cancer 23: 42–46.PubMedCrossRefGoogle Scholar
  56. Pearse, A., and Ioachim, H. L., 1978, Effect of host immunity on tumor cell antigenic variability, Proc. Am. Assoc. Cancer Res. 18: 175.Google Scholar
  57. Phillips, T. M., and Lewis, M. G., 1971, A method for elution of immunoglobulin from the surface of living cells, Rev. Eur. Etud. Clin. Biol. 16: 1052–1055.PubMedGoogle Scholar
  58. Ran, M., and Witz, I. P., 1972, Tumor-associated immunoglobulins. Enhancement of syngeneic tumors by IgG2-containing tumor eluates, Int. J. Cancer 9: 242–247.PubMedCrossRefGoogle Scholar
  59. Russel, B. R. G., 1908, The nature of resistance to the inoculation of cancer, Third Scientific Rep. Imperial Cancer Res. Fund. 3: 341–358.Google Scholar
  60. Sjögren, H. 0., He dström, I., Bansal, S.C., Warner, G. A., and Hellström, K. E., 1972, Elution of “blocking factors” from human tumors capable of abrogating tumor-cell destruction by specifically immune lymphocytes, Int. J. Cancer 9:274–283.Google Scholar
  61. Sobczac, E., and De Vaux Saint Cyr, C., 1971, Study of the in vivo fixation of antibodies on tumors provoked in hamsters by injection of SV40-transformed cells (TSV5Ci2), Int. J. Cancer 8: 47–52.CrossRefGoogle Scholar
  62. Stjernsward, J., Jondal, M., Vanky, F., Wigzell, H., and Sealy, R., 1972, Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma, Lancet 1: 1352–1356.PubMedCrossRefGoogle Scholar
  63. Takahashi, K., 1961, Squamous cell carcinoma of the esophagus. Stromal inflammatory cell infiltration as a prognostic factor, Cancer 14: 921–933.PubMedCrossRefGoogle Scholar
  64. Thunold, S., T$nder, O., and Larsen, 0., 1973, Immunoglobulins in eluates of malignant human tumors, Acta Pathol. Microbiol. Scand. Sect. A (Suppl.) 236: 97–100.Google Scholar
  65. Underwood, J. C. E., 1972, Lymphoreticular infiltration in human tumors—Prognostic and biological implications, a review. Br. J. Cancer 30: 538–547.CrossRefGoogle Scholar
  66. von Kleist, S., King, M., and Burtin P., 1974, Characterization of a normal tissular antigen extracted from human colonic tumors, Immunochemistry 11: 249–253.PubMedCrossRefGoogle Scholar
  67. Witz, I. P., 1973, The biological significance of tumor-bound immunoglobulins. Curr. Top. Microbiol. Immunol. 61: 151–171.PubMedGoogle Scholar
  68. Zeromski, J., Gorny, M. K., Wruk, M., and Sapula, J., 1975, Behaviour of local and systemic immunoglobulins in patients with lung cancer, Int. Arch. Allergy Appl. Immunol. 49: 548–563.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • Harry L. Ioachim
    • 1
    • 2
  1. 1.Department of PathologyLenox Hill HospitalNew YorkUSA
  2. 2.Department of PathologyCollege of Physicians and Surgeons Columbia UniversityNew YorkUSA

Personalised recommendations